MedMira Cash Per Share vs Days Payables Outstanding Analysis
MIR Stock | CAD 0.08 0.00 0.00% |
MedMira financial indicator trend analysis is infinitely more than just investigating MedMira recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MedMira is a good investment. Please check the relationship between MedMira Cash Per Share and its Days Payables Outstanding accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Cash Per Share vs Days Payables Outstanding
Cash Per Share vs Days Payables Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MedMira Cash Per Share account and Days Payables Outstanding. At this time, the significance of the direction appears to have very week relationship.
The correlation between MedMira's Cash Per Share and Days Payables Outstanding is 0.28. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Days Payables Outstanding in the same time period over historical financial statements of MedMira, assuming nothing else is changed. The correlation between historical values of MedMira's Cash Per Share and Days Payables Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of MedMira are associated (or correlated) with its Days Payables Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Payables Outstanding has no effect on the direction of Cash Per Share i.e., MedMira's Cash Per Share and Days Payables Outstanding go up and down completely randomly.
Correlation Coefficient | 0.28 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Cash Per Share
Days Payables Outstanding
Most indicators from MedMira's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MedMira current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Selling General Administrative is likely to climb to about 1.2 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 304.0K | 300.4K | 345.4K | 328.2K | Total Revenue | 952.1K | 432.5K | 497.4K | 472.5K |
MedMira fundamental ratios Correlations
Click cells to compare fundamentals
MedMira Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MedMira fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.4M | 3.9M | 3.8M | 3.7M | 3.3M | 1.7M | |
Short Long Term Debt Total | 11.9M | 11.5M | 8.3M | 9.3M | 10.7M | 9.1M | |
Other Current Liab | 3.5M | 4.2M | 4.5M | 5.4M | 6.2M | 6.5M | |
Total Current Liabilities | 15.8M | 17.4M | 14.1M | 15.7M | 18.1M | 11.7M | |
Total Stockholder Equity | (15.6M) | (15.7M) | (12.4M) | (15.0M) | (13.5M) | (14.2M) | |
Property Plant And Equipment Net | 2.5M | 2.3M | 2.2M | 2.0M | 2.3M | 2.4M | |
Net Debt | 11.5M | 13.8M | 8.3M | 9.3M | 10.6M | 9.2M | |
Retained Earnings | (92.8M) | (93.5M) | (95.3M) | (98.0M) | (88.2M) | (92.6M) | |
Cash | 401.9K | (2.3M) | 33.5K | 13.2K | 15.2K | 15.9K | |
Non Current Assets Total | 2.5M | 2.3M | 2.2M | 2.0M | 2.3M | 2.4M | |
Cash And Short Term Investments | 401.9K | (2.3M) | 33.5K | 13.2K | 15.2K | 15.9K | |
Net Receivables | 207.8K | 1.3M | 1.4M | 1.4M | 1.6M | 1.7M | |
Liabilities And Stockholders Equity | 3.4M | 3.9M | 3.8M | 3.7M | 3.3M | 1.7M | |
Non Current Liabilities Total | 3.2M | 2.2M | 2.0M | 3.0M | 2.7M | 1.7M | |
Inventory | 222.6K | 235.8K | 202.0K | 182.4K | 164.2K | 156.0K | |
Other Current Assets | 78.8K | 2.4M | 53.9K | 69.2K | 79.6K | 75.6K | |
Total Liab | 19.0M | 19.6M | 16.2M | 18.7M | 21.5M | 13.9M | |
Total Current Assets | 911.1K | 1.6M | 1.7M | 1.7M | 1.5M | 1.1M | |
Short Term Debt | 8.8M | 9.3M | 6.3M | 6.3M | 7.3M | 7.3M | |
Accounts Payable | 2.3M | 2.7M | 2.7M | 3.3M | 3.8M | 2.8M | |
Other Stockholder Equity | 2.7M | 7.8K | 29.5K | (2.5K) | (2.3K) | (2.1K) | |
Accumulated Other Comprehensive Income | 11.0M | 13.8M | 13.8M | 14.6M | 16.8M | 17.6M | |
Current Deferred Revenue | 1.2M | 1.2M | 596.7K | 749.9K | 862.4K | 507.5K | |
Net Tangible Assets | (13.5M) | (15.6M) | (15.7M) | (12.4M) | (11.1M) | (11.7M) | |
Short Long Term Debt | 8.6M | 9.2M | 6.1M | 6.1M | 7.1M | 7.1M | |
Property Plant Equipment | 6.7K | 2.5M | 2.3M | 2.2M | 2.5M | 2.6M | |
Net Invested Capital | (6.1M) | (6.5M) | (6.2M) | (7.8M) | (7.0M) | (7.3M) | |
Net Working Capital | (14.9M) | (15.8M) | (12.5M) | (14.0M) | (12.6M) | (13.3M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.